NEU²

new drugs
against
neurological diseases

 
 

News and press releases

2013-06-17: press release

Lophius Biosciences GmbH joins NEU² and receives substantial grant funding for the diagnosis and monitoring of multiple sclerosis

Lophius has joined the NEU² program with a project addressing the development of a novel blood-based diagnostic test for multiple sclerosis. read more …

2013-05-21: press release

Baliopharm GmbH joins NEU²

press release News and press releases Schleswig/Hamburg, Germany – May 2013: Bionamics GmbH, the coordinator of the NEU² consortium, is pleased to announce that Baliopharm GmbH (the german subsidiary of Baliopharm AG, Basel/Switzerland) joined the NEU² program with a project addressing the recombinant manufacturing of a Fc-free bispecific CD20-CD95 antibody construct (Novotarg)… read more …

Archives

Sponsored by:

and supported by: